Doxefazepam

Jump to: navigation, search
Doxefazepam
Doxefazepam.png
Doxefazepam3d.png
Clinical data
Pregnancy
category
  •  ?
Routes of
administration
Oral
ATC code
Legal status
Legal status
Pharmacokinetic data
Bioavailability?
MetabolismHepatic
Elimination half-life3-4 hours[1]
ExcretionRenal
Identifiers
CAS Number
PubChem CID
DrugBank
ChemSpider
UNII
KEGG
ChEMBL
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC17H14ClFN2O3
Molar mass348.8
3D model (JSmol)
 ☒N☑Y (what is this?)

WikiDoc Resources for Doxefazepam

Articles

Most recent articles on Doxefazepam

Most cited articles on Doxefazepam

Review articles on Doxefazepam

Articles on Doxefazepam in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Doxefazepam

Images of Doxefazepam

Photos of Doxefazepam

Podcasts & MP3s on Doxefazepam

Videos on Doxefazepam

Evidence Based Medicine

Cochrane Collaboration on Doxefazepam

Bandolier on Doxefazepam

TRIP on Doxefazepam

Clinical Trials

Ongoing Trials on Doxefazepam at Clinical Trials.gov

Trial results on Doxefazepam

Clinical Trials on Doxefazepam at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Doxefazepam

NICE Guidance on Doxefazepam

NHS PRODIGY Guidance

FDA on Doxefazepam

CDC on Doxefazepam

Books

Books on Doxefazepam

News

Doxefazepam in the news

Be alerted to news on Doxefazepam

News trends on Doxefazepam

Commentary

Blogs on Doxefazepam

Definitions

Definitions of Doxefazepam

Patient Resources / Community

Patient resources on Doxefazepam

Discussion groups on Doxefazepam

Patient Handouts on Doxefazepam

Directions to Hospitals Treating Doxefazepam

Risk calculators and risk factors for Doxefazepam

Healthcare Provider Resources

Symptoms of Doxefazepam

Causes & Risk Factors for Doxefazepam

Diagnostic studies for Doxefazepam

Treatment of Doxefazepam

Continuing Medical Education (CME)

CME Programs on Doxefazepam

International

Doxefazepam en Espanol

Doxefazepam en Francais

Business

Doxefazepam in the Marketplace

Patents on Doxefazepam

Experimental / Informatics

List of terms related to Doxefazepam

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]


Overview

Doxefazepam (marketed under brand name Doxans) is a benzodiazepine derivative drug developed by Schiapparelli in the 1970s.[2] It possesses anxiolytic, anticonvulsant, sedative and skeletal muscle relaxant properties. It is used therapeutically as a hypnotic.[3] According to Babbini and colleagues in 1975, this derivative of flurazepam was between 2 and 4 times more potent than the latter while at the same time being half as toxic in laboratory animals.[4] Section 5.5 of the article Doxefazepam in volume 66 of the World Health Organization's (WHO) and International Agency for Research on Cancer's (IARC) IARC Monographs On The Evaluation Of Carcinogenic Risks To Humans, an article describing the carcinogenic/toxic effects of doxefazepam on humans and experimental animals, states that there is "inadequate evidence in humans for the carcinogenicity of doxefazepam" and limited evidence in experimental for the carcinogenicity of doxefazepam," and concluded that the overall evaluation of the substance's carcinogenicity to humans is "not classifiable."[5]

See also

References

  1. http://www.intox.org/databank/documents/pharm/doxefzpm/iarc796.htm
  2. DE Patent 2338058 - BENZODIAZEPINVERBINDUNGEN FUER DIE THERAPIE
  3. Rodriguez, G; Rosadini, G; Sannita, WG; Strumia, E (1984). "Effects of doxefazepam on normal sleep. An EEG and neuropsychological study". Neuropsychobiology. 11 (2): 133–9. doi:10.1159/000118066. PMID 6483162.
  4. Babbini, M. (August 1975). "Sedative-hypnotic properties of a new benzodiazepine in comparison with flurazepam. Pharmacological and clinical findings". Arzneimittel-Forschung. 25 (8): 1294–1300. PMID 241364. Unknown parameter |coauthors= ignored (help)
  5. "Doxefazepam" (PDF). IARC Monographs On The Evaluation Of Carcinogenic Risks To Humans. International Agency For Research On Cancer (IARC). 66: 97–104. 13–20 Feb 1996. Retrieved 10 July 2014.

External links


Linked-in.jpg